{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:13:49Z","timestamp":1792685629090,"version":"4.5.0"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.biopha.2015.12.014","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T07:26:02Z","timestamp":1451373962000},"page":"98-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"special_numbering":"C","title":["Nanoparticles: Novel vehicles in treatment of Glioblastoma"],"prefix":"10.1016","volume":"77","author":[{"given":"Fatemeh","family":"Pourgholi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"hajivalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadidi-Niaragh","family":"Farhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein Samadi","family":"Kafil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2015.12.014_bib0005","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","article-title":"Global cancer transitions according to the Human Development Index (2008\u20132030): a population-based study","volume":"13","author":"Bray","year":"2012","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.biopha.2015.12.014_bib0010","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PloS Med."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jocn.2014.09.001","article-title":"A novel treatment strategy for glioblastoma multiforme and glioma associated seizures: increasing glutamate uptake with PPAR\u03b3 agonists","volume":"22","author":"Ching","year":"2015","journal-title":"J. Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2015.12.014_bib0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.critrevonc.2008.02.005","article-title":"Glioblastoma in adults","volume":"67","author":"Brandes","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.biopha.2015.12.014_bib0025","series-title":"Current Understanding and Treatment of Gliomas","first-page":"1","article-title":"Epidemiology of gliomas","author":"Ostrom","year":"2015"},{"issue":"4","key":"10.1016\/j.biopha.2015.12.014_bib0030","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1021\/nl052396o","article-title":"Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells","volume":"6","author":"Chithrani","year":"2006","journal-title":"Nano Lett."},{"issue":"10","key":"10.1016\/j.biopha.2015.12.014_bib0035","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1602\/neurorx.2.1.1","article-title":"The blood-brain barrier and neurotherapeutics","volume":"2","author":"Pardridge","year":"2005","journal-title":"Neurotherapeutics"},{"issue":"23","key":"10.1016\/j.biopha.2015.12.014_bib0045","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1002\/cncr.26188","article-title":"Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy","volume":"117","author":"Reardon","year":"2011","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.biopha.2015.12.014_bib0050","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1016\/j.watres.2006.08.004","article-title":"Comparative eco-toxicity of nanoscale TiO2, SiO2, and ZnO water suspensions","volume":"40","author":"Adams","year":"2006","journal-title":"Water Res."},{"issue":"3","key":"10.1016\/j.biopha.2015.12.014_bib0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp. Mol. Pathol."},{"issue":"6","key":"10.1016\/j.biopha.2015.12.014_bib0060","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4155\/tde.13.38","article-title":"Therapeutic nanomedicine for brain cancer","volume":"4","author":"Tzeng","year":"2013","journal-title":"Ther. Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.55782\/ane-2011-1828","article-title":"In vitro models of the blood-brain barrier","volume":"71","author":"Wilhelm","year":"2011","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"issue":"2","key":"10.1016\/j.biopha.2015.12.014_bib0070","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.biopha.2015.12.014_bib0075","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00066-007-1739-5","article-title":"Postoperative radiotherapy of glioblastoma multiforme","volume":"183","author":"Piroth","year":"2007","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.biopha.2015.12.014_bib0080","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00012","article-title":"Immunotherapeutic advancements for glioblastoma","volume":"5","author":"Ampie","year":"2015","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2015.12.014_bib0085","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/14737140.2014.921571","article-title":"Dendritic cell immunotherapy for glioblastoma","volume":"14","author":"Polyzoidis","year":"2014","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"7","key":"10.1016\/j.biopha.2015.12.014_bib0090","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/cncr.28935","article-title":"Bevacizumab and glioblastoma: scientific review, newly reported updates, and ongoing controversies","volume":"121","author":"Field","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2015.12.014_bib0095","first-page":"2863","article-title":"Nanoparticles for hyperthermic therapy: synthesis strategies and applications in glioblastoma","author":"Verma","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2015.12.014_bib0100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/B:NEON.0000021803.01170.03","article-title":"Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme","volume":"67","author":"Baumann","year":"2004","journal-title":"J. Neuro-oncol."},{"issue":"6","key":"10.1016\/j.biopha.2015.12.014_bib0105","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.addr.2007.04.008","article-title":"Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles","volume":"59","author":"Wong","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"25","key":"10.1016\/j.biopha.2015.12.014_bib0110","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2007.11.5964","article-title":"Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity","volume":"26","author":"Hegi","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.biopha.2015.12.014_bib0115","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-06-0913","article-title":"Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting","volume":"12","author":"Sok","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2015.12.014_bib0120","doi-asserted-by":"crossref","DOI":"10.1517\/13543770902967666","article-title":"Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches","author":"Dumont","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.biopha.2015.12.014_bib0125","series-title":"Assessment of Drug Resistance in Anticancer Therapy by Nuclear Imaging, in Drug Resistance in Cancer Cells","first-page":"295","author":"Charnley","year":"2009"},{"key":"10.1016\/j.biopha.2015.12.014_bib0130","article-title":"Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide","author":"Messaoudi","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"7","key":"10.1016\/j.biopha.2015.12.014_bib0135","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1248\/bpb.34.1058","article-title":"Improving efficiency of adriamycin crossing blood brain barrier by combination of thermosensitive liposomes and hyperthermia","volume":"34","author":"Gong","year":"2011","journal-title":"Biol. Pharm. Bull."},{"issue":"26","key":"10.1016\/j.biopha.2015.12.014_bib0140","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1039\/b804274h","article-title":"Shape-controlled synthesis of protein-conjugated silver sulfide nanocrystals and study on the inhibition of tumor cell viability","author":"Yang","year":"2008","journal-title":"Chem. Commun."},{"key":"10.1016\/j.biopha.2015.12.014_bib0145","series-title":"Hyperthermia In Cancer Treatment: A Primer: A Primer","author":"Baronzio","year":"2008"},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","article-title":"The cellular and molecular basis of hyperthermia","volume":"43","author":"Hildebrandt","year":"2002","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"14","key":"10.1016\/j.biopha.2015.12.014_bib0155","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1039\/b402025a","article-title":"Magnetic nanoparticle design for medical diagnosis and therapy","volume":"14","author":"Mornet","year":"2004","journal-title":"J. Mater. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2015.12.014_bib0160","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00000658-195710000-00007","article-title":"Selective inductive heating of lymph nodes","volume":"146","author":"Gilchrist","year":"1957","journal-title":"Ann. Surg."},{"key":"10.1016\/j.biopha.2015.12.014_bib0165","first-page":"1","article-title":"Detecting cryptic epitopes created by nanoparticles","volume":"327","author":"Lynch","year":"2006","journal-title":"Sci. STKE"},{"issue":"2","key":"10.1016\/j.biopha.2015.12.014_bib0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2007.12.018","article-title":"Potential of solid lipid nanoparticles in brain targeting","volume":"127","author":"Kaur","year":"2008","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0175","first-page":"9","article-title":"CNS targeted drug delivery: current perspectives","volume":"1","author":"Rasheed","year":"2010","journal-title":"JITPS"},{"issue":"3","key":"10.1016\/j.biopha.2015.12.014_bib0180","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejpb.2006.11.009","article-title":"A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes","volume":"65","author":"Letchford","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nano.2005.12.003","article-title":"Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles","volume":"2","author":"Reis","year":"2006","journal-title":"Nanomedicine"},{"issue":"3","key":"10.1016\/j.biopha.2015.12.014_bib0190","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejpb.2004.09.002","article-title":"Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone","volume":"59","author":"Teixeira","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.biopha.2015.12.014_bib0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","article-title":"Drug delivery and nanoparticles: applications and hazards","volume":"3","author":"De Jong","year":"2008","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.biopha.2015.12.014_bib0200","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood-brain barrier","volume":"64","author":"Chen","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2015.12.014_bib0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2009.01.011","article-title":"Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model","volume":"1261","author":"Wang","year":"2009","journal-title":"Brain Res."},{"issue":"0","key":"10.1016\/j.biopha.2015.12.014_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/21691401.2014.998830","article-title":"The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy","author":"Hosseini","year":"2015","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"2","key":"10.1016\/j.biopha.2015.12.014_bib0215","first-page":"252","article-title":"Drug delivery to the central nervous system: a review","volume":"6","author":"Misra","year":"2003","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2015.12.014_bib0220","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4155\/tde.10.13","article-title":"Nanoparticle-assisted combination therapies for effective cancer treatment","volume":"1","author":"Hu","year":"2010","journal-title":"Ther. Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/jcbfm.2009.192","article-title":"Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review","volume":"30","author":"Weinstein","year":"2010","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.biopha.2015.12.014_bib0230","unstructured":"Y., Shi, Self-Assembled Gold Nanoplexes for Cancer-Targeted siRNA Delivery. 2014. Master theses, paper 37."},{"issue":"5","key":"10.1016\/j.biopha.2015.12.014_bib0235","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1734-1140(12)70901-5","article-title":"Nanoparticles as drug delivery systems","volume":"64","author":"Wilczewska","year":"2012","journal-title":"Pharmacol. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2015.12.014_bib0240","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s11095-006-0284-8","article-title":"Nanotechnology: intelligent design to treat complex disease","volume":"23","author":"Couvreur","year":"2006","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0245","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2009.10.003","article-title":"Targeted delivery of low molecular drugs using chitosan and its derivatives","volume":"62","author":"Park","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2015.12.014_bib0250","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.biomaterials.2010.09.002","article-title":"PEGylated poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors","volume":"32","author":"He","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2015.12.014_bib0255","doi-asserted-by":"crossref","DOI":"10.1517\/17425240903061251","article-title":"Surface modified poly(amido) amine dendrimers as diverse nanomolecules for biomedical applications","volume":"6","author":"Yellepeddi","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf. B"},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0265","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/08982101003754377","article-title":"Study of the pilot production process of long-circulating and pH-sensitive liposomes containing cisplatin","volume":"21","author":"Santos Giuberti","year":"2011","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.biopha.2015.12.014_bib0270","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/351031","article-title":"Application of nanoparticles on diagnosis and therapy in gliomas","volume":"2013","author":"Hern\u00e1ndez-Pedro","year":"2013","journal-title":"BioMed Res. Int."},{"issue":"12","key":"10.1016\/j.biopha.2015.12.014_bib0275","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1021\/bc200406n","article-title":"In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles","volume":"22","author":"Jin","year":"2011","journal-title":"Bioconjugate Chem."},{"issue":"2","key":"10.1016\/j.biopha.2015.12.014_bib0280","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.2042-7158.2010.01167.x","article-title":"Advancement in carbon nanotubes: basics, biomedical applications and toxicity","volume":"63","author":"Beg","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2015.12.014_bib0285","first-page":"239","article-title":"Carbon nanohorns as a novel drug carrier","volume":"64","author":"Shiba","year":"2006","journal-title":"Nihon Rinsho Jpn. J. Clin. Med."},{"issue":"26","key":"10.1016\/j.biopha.2015.12.014_bib0290","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1016\/j.biomaterials.2012.05.020","article-title":"Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(\u03b5-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy","volume":"33","author":"Gao","year":"2012","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.biopha.2015.12.014_bib0295","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/nbt1171","article-title":"Designing dendrimers for biological applications","volume":"23","author":"Lee","year":"2005","journal-title":"Nature Biotechnol."},{"issue":"29","key":"10.1016\/j.biopha.2015.12.014_bib0300","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.2174\/0929867311209025101","article-title":"Dendrimers as vectors for genetic material delivery to the nervous system","volume":"19","author":"Perez-Martinez","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"21","key":"10.1016\/j.biopha.2015.12.014_bib0305","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1016\/j.biomaterials.2012.04.032","article-title":"Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles","volume":"33","author":"Zhang","year":"2012","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.biopha.2015.12.014_bib0310","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1021\/nn405356r","article-title":"Heat-generating iron oxide nanocubes: subtle destructurators of the tumoral microenvironment","volume":"8","author":"Kolosnjaj-Tabi","year":"2014","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.biopha.2015.12.014_bib0315","first-page":"591","article-title":"Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment","volume":"6","author":"Silva","year":"2011","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0320","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jbm.820190107","article-title":"Regulation of drug release from polymer matrices by oscillating magnetic fields","volume":"19","author":"Edelman","year":"1985","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.biopha.2015.12.014_bib0325","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jcis.2014.07.032","article-title":"99m Tc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of \u03b1(\u03b23-mediated tumor expression and feasibility for hyperthermia treatment","volume":"433","author":"Tsiapa","year":"2014","journal-title":"J. Colloid Interface Sci."},{"issue":"7","key":"10.1016\/j.biopha.2015.12.014_bib0330","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1039\/C2CS35367A","article-title":"Gold nanorods and their plasmonic properties","volume":"42","author":"Chen","year":"2013","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0335","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/02656736.2012.753162","article-title":"Role of optical coefficients and healthy tissue-sparing characteristics in gold nanorod-assisted thermal therapy","volume":"29","author":"Soni","year":"2013","journal-title":"Int. J. Hyperthermia"},{"issue":"2","key":"10.1016\/j.biopha.2015.12.014_bib0340","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s10439-011-0472-5","article-title":"Tunable nanostructures as photothermal theranostic agents","volume":"40","author":"Young","year":"2012","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.biopha.2015.12.014_bib0345","first-page":"1511","article-title":"Induction of cell death in a glioblastoma line by hyperthermic therapy based on gold nanorods","volume":"7","author":"Cabada","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.biopha.2015.12.014_bib0350","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/adfm.201002253","article-title":"Specific near-IR Absorption imaging of glioblastomas using integrin-targeting gold nanorods","volume":"21","author":"Choi","year":"2011","journal-title":"Adv. Funct. Mater."},{"issue":"6","key":"10.1016\/j.biopha.2015.12.014_bib0355","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1021\/nn201010q","article-title":"Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods","volume":"5","author":"Agarwal","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2015.12.014_bib0360","first-page":"18","article-title":"Aptamer conjugated gold nanorods for targeted nanothermal radiation of Glioblastoma cancer cells (A novel selective targeted approach to cancer treatment)","author":"Oli","year":"2010","journal-title":"Young Sci. J."},{"issue":"8","key":"10.1016\/j.biopha.2015.12.014_bib0365","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7150\/thno.4756","article-title":"Gold nanorods conjugated with doxorubicin and cRGD for combined anticancer drug delivery and PET imaging","volume":"2","author":"Xiao","year":"2012","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.biopha.2015.12.014_bib0370","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1021\/mp500720a","article-title":"One platform comparison of estrone and folic acid anchored surface engineered MWCNTs for doxorubicin delivery","volume":"12","author":"Mehra","year":"2015","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0375","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nano.2010.06.010","article-title":"Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody","volume":"7","author":"Wang","year":"2011","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0380","first-page":"179","article-title":"Targeted drug delivery to CNS using nanoparticles","volume":"2","author":"Dikpati","year":"2012","journal-title":"JAPS J."},{"issue":"4","key":"10.1016\/j.biopha.2015.12.014_bib0385","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/mp900090z","article-title":"Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery","volume":"6","author":"Gullotti","year":"2009","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2015.12.014_bib0390","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00432-014-1767-3","article-title":"Cancer active targeting by nanoparticles: a comprehensive review of literature","volume":"141","author":"Bazak","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0395","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2011.05.008","article-title":"TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes","volume":"154","author":"Guo","year":"2011","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.biopha.2015.12.014_bib0400","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2015.12.014_bib0405","first-page":"2300","article-title":"Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein","volume":"60","author":"Malet\u00ednsk\u00e1","year":"2000","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2015.12.014_bib0410","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MOL.0b013e3283532947","article-title":"Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor","volume":"23","author":"Sorrentino","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"issue":"2","key":"10.1016\/j.biopha.2015.12.014_bib0415","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0169-409X(01)00109-0","article-title":"Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting","volume":"47","author":"Rensen","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"36","key":"10.1016\/j.biopha.2015.12.014_bib0420","doi-asserted-by":"crossref","first-page":"9171","DOI":"10.1016\/j.biomaterials.2013.08.039","article-title":"LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"issue":"22","key":"10.1016\/j.biopha.2015.12.014_bib0425","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1016\/j.biomaterials.2013.04.025","article-title":"Glioma therapy using tumor homing and penetrating peptide-functionalized PEG\u2013PLA nanoparticles loaded with paclitaxel","volume":"34","author":"Hu","year":"2013","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.biopha.2015.12.014_bib0430","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1016\/j.biomaterials.2011.12.046","article-title":"The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model","volume":"33","author":"Dilnawaz","year":"2012","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.biopha.2015.12.014_bib0435","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(00)81433-6","article-title":"Cyclooxygenase regulates angiogenesis induced by colon cancer cells","volume":"93","author":"Tsujii","year":"1998","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.biopha.2015.12.014_bib0440","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/neuonc\/not062","article-title":"Celecoxib enhances radiosensitivity of hypoxic glioblastoma cells through endoplasmic reticulum stress","volume":"15","author":"Suzuki","year":"2013","journal-title":"Neuro Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2015.12.014_bib0445","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s11307-014-0734-3","article-title":"Combination treatment with theranostic nanoparticles for glioblastoma sensitization to TMZ","volume":"16","author":"Yoo","year":"2014","journal-title":"Mol. Imaging Biol."},{"issue":"5","key":"10.1016\/j.biopha.2015.12.014_bib0450","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1593\/neo.09230","article-title":"The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases","volume":"11","author":"Pillay","year":"2009","journal-title":"Neoplasia"},{"issue":"32","key":"10.1016\/j.biopha.2015.12.014_bib0455","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1016\/j.biomaterials.2012.07.046","article-title":"Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles","volume":"33","author":"Xin","year":"2012","journal-title":"Biomaterials"},{"issue":"18","key":"10.1016\/j.biopha.2015.12.014_bib0460","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1016\/j.biomaterials.2011.02.044","article-title":"Angiopep-conjugated poly(ethylene glycol)-co-poly (\u03b5caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma","volume":"32","author":"Xin","year":"2011","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.biopha.2015.12.014_bib0465","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00018-008-7452-4","article-title":"Curcumin: from ancient medicine to current clinical trials","volume":"65","author":"Hatcher","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2015.12.014_bib0470","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2008.03.009","article-title":"Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins","volume":"269","author":"Kunnumakkara","year":"2008","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.biopha.2015.12.014_bib0475","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1208\/s12248-009-9128-x","article-title":"Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?","volume":"11","author":"Ravindran","year":"2009","journal-title":"AAPS J."},{"issue":"3","key":"10.1016\/j.biopha.2015.12.014_bib0480","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ejpb.2013.07.013","article-title":"Enhanced accumulation of curcumin and temozolomide loaded magnetic nanoparticles executes profound cytotoxic effect in glioblastoma spheroid model","volume":"85","author":"Dilnawaz","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.biopha.2015.12.014_bib0485","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1021\/cr900197g","article-title":"Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications","volume":"110","author":"Laurent","year":"2009","journal-title":"Chem. Rev."},{"issue":"15","key":"10.1016\/j.biopha.2015.12.014_bib0490","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.1158\/0008-5472.CAN-10-1022","article-title":"EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma","volume":"70","author":"Hadjipanayis","year":"2010","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.biopha.2015.12.014_bib0495","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/mt.2008.185","article-title":"Therapeutic efficacy of a herpes simplex virus with radiation or temozolomide for intracranial glioblastoma after convection-enhanced delivery","volume":"16","author":"Hadjipanayis","year":"2008","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2015.12.014_bib0500","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3171\/jns.1995.83.6.1029","article-title":"Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy","volume":"83","author":"Siegal","year":"1995","journal-title":"J. Neurosurg."},{"issue":"4","key":"10.1016\/j.biopha.2015.12.014_bib0505","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003495-199700544-00005","article-title":"Polyethylene glycol-coated (pegylated) liposomal doxorubicin","volume":"54","author":"Gabizon","year":"1997","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.biopha.2015.12.014_bib0510","doi-asserted-by":"crossref","first-page":"e19121","DOI":"10.1371\/journal.pone.0019121","article-title":"Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers","volume":"6","author":"Wohlfart","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2015.12.014_bib0515","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/975763","article-title":"Chlorotoxin fused to IgG-Fc inhibits glioblastoma cell motility via receptor-mediated endocytosis","volume":"2012","author":"Kasai","year":"2012","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.biopha.2015.12.014_bib0520","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.neuroimage.2007.03.078","article-title":"Internalization of MWCNTs by microglia: possible application in immunotherapy of brain tumors","volume":"37","author":"Kateb","year":"2007","journal-title":"Neuroimage"},{"issue":"7","key":"10.1016\/j.biopha.2015.12.014_bib0525","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1166\/jnn.2015.10298","article-title":"Applications of nanoparticles for anticancer drug delivery: a review","volume":"15","author":"Zhu","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"28","key":"10.1016\/j.biopha.2015.12.014_bib0530","doi-asserted-by":"crossref","first-page":"8130","DOI":"10.1039\/c1cc12007g","article-title":"Imaging brain tumor by dendrimer-based optical\/paramagnetic nanoprobe across the blood-brain barrier","volume":"47","author":"Yan","year":"2011","journal-title":"Chem. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2015.12.014_bib0535","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1163\/156856209X415828","article-title":"Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro","volume":"21","author":"Ren","year":"2010","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0540","first-page":"119","article-title":"MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis","volume":"40","author":"Shi","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.biopha.2015.12.014_bib0545","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2174\/1389201015666141031105234","article-title":"Targeted delivery of tumor suppressor microRNA-1 by transferrin-conjugated lipopolyplex nanoparticles to patient-derived glioblastoma stem cells","volume":"15","author":"Wang","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"3","key":"10.1016\/j.biopha.2015.12.014_bib0550","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-003-0803-1","article-title":"Perinecrotic glioma proliferation and metabolic profile within an intracerebral tumor xenograft","volume":"107","author":"Gorin","year":"2004","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0555","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.biomaterials.2013.09.094","article-title":"Nanoparticles of 2-deoxy-d-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment","volume":"35","author":"Jiang","year":"2014","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0560","doi-asserted-by":"crossref","first-page":"e82331","DOI":"10.1371\/journal.pone.0082331","article-title":"Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)","volume":"9","author":"Gaillard","year":"2014","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.biopha.2015.12.014_bib0565","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1016\/j.biomaterials.2011.01.048","article-title":"Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor","volume":"32","author":"Kuo","year":"2011","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biopha.2015.12.014_bib0570","first-page":"405","article-title":"Solid lipid nanoparticles: a novel carrier for cancer therapy","volume":"3","author":"Chimmiri","year":"2012","journal-title":"Int. J. Biol. Pharm. Res."},{"issue":"5","key":"10.1016\/j.biopha.2015.12.014_bib0575","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/02652040600788080","article-title":"Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model","volume":"23","author":"Ambruosi","year":"2006","journal-title":"J. Microencapsulation"},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0580","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijpharm.2010.10.005","article-title":"Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly (\u03b5-caprolactone) nanoparticles: in vitro and in vivo evaluation","volume":"402","author":"Xin","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0585","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijpharm.2014.12.070","article-title":"Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin-and folic acid-grafted poly(lactide-co-glycolide) nanoparticles","volume":"479","author":"Kuo","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2015.12.014_bib0590","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1227\/NEU.0b013e31826989ef","article-title":"Canine model of convection-enhanced delivery of cetuximab conjugated iron-oxide nanoparticles monitored with magnetic resonance imaging","volume":"59","author":"Platt","year":"2012","journal-title":"Clin. Neurosurg."},{"key":"10.1016\/j.biopha.2015.12.014_bib0595","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jcis.2015.03.019","article-title":"CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery","volume":"450","author":"Zhao","year":"2015","journal-title":"J. Colloid Interface Sci."},{"issue":"1","key":"10.1016\/j.biopha.2015.12.014_bib0600","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11060-005-9059-z","article-title":"The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma","volume":"78","author":"Jordan","year":"2006","journal-title":"J. Neuro-oncol."},{"issue":"47","key":"10.1016\/j.biopha.2015.12.014_bib0605","doi-asserted-by":"crossref","first-page":"17451","DOI":"10.1021\/jp0773177","article-title":"Surface plasmon resonance sensitivity of metal nanostructures: physical basis and universal scaling in metal nanoshells","volume":"111","author":"Jain","year":"2007","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.biopha.2015.12.014_bib0610","article-title":"Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis","volume":"2011","author":"Morrison","year":"2010","journal-title":"J. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2015.12.014_bib0615","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.20048","article-title":"Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles","volume":"109","author":"Steiniger","year":"2004","journal-title":"Int. J. Cancer"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221530233X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221530233X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:00:03Z","timestamp":1760094003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333221530233X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":123,"alternative-id":["S075333221530233X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2015.12.014","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticles: Novel vehicles in treatment of Glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2015.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}